PALYNZIQ

Serial Number 87516646
606

Registration Progress

Application Filed
Jul 5, 2017
Under Examination
Jan 2, 2018
Approved for Publication
Nov 7, 2017
Published for Opposition
Nov 7, 2017
Registered

Trademark Image

PALYNZIQ

Basic Information

Serial Number
87516646
Filing Date
July 5, 2017
Published for Opposition
November 7, 2017
Abandonment Date
February 8, 2021
Drawing Code
5000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 8, 2021
Classes
005

Rights Holder

Biomarin Pharmaceutical Inc.

03
Address
105 Digital Drive
Novato, CA 94949

Ownership History

Biomarin Pharmaceutical Inc.

Original Applicant
03
Novato, CA

Biomarin Pharmaceutical Inc.

Owner at Publication
03
Novato, CA

Legal Representation

Attorney
Gregory J. Chinlund

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

39 events
Date Code Type Description Documents
Feb 8, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 8, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 9, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 9, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 9, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Dec 9, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 22, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 21, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 21, 2020 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 29, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 29, 2020 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 4, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 2, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 2, 2019 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 2, 2019 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 19, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 17, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 17, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 17, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 17, 2019 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 30, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 4, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 2, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 2, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 2, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 2, 2019 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 30, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 28, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 28, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 28, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 28, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 2, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 7, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 7, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 18, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 28, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 28, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 12, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 8, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for use in enzyme therapy
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of an upper-case of letter "P" and the lower-case letters of "alynziq" with a middle line of the letter "z" broken from the top horizontal line and the bottom horizontal line.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005